Managers
Private assets have experienced significant growth in the last few years and Ireland is now set up to further benefit from this expansion through the Investment Limited Partnerships (Amendment) Act 2020 (ILP Act) which was enacted into law in December 2020.
“Private equity funds have performed well and are increasingly popular with investors and asset managers alike,” observes Vanora Madigan, executive director, DMS Governance, “These funds are established in Ireland as Qualifying Investor Alternative Investment Funds (QIAIFs) which have few investment restrictions and allow PE managers to raise capital within the EU marketplace with relative ease by availing of the
Managers looking to take advantage of the new structure launched in Ireland, the Investment Limited Partnership (ILP), will be able to maximise cost efficiency and time-to-market. The Irish legislation allows the adoption of an umbrella structure, meaning managers can launch sub-funds swiftly and save on legal and audit fees.
“A General Partner (“GP”) can have sub funds in the LP, which have segregated liability between them. This offers speed to market for those sub-funds since the manager will have the legal structure and the necessary service providers all lined up for the umbrella fund. Therefore, adding a sub-fund will not
In a hunt for yield, investors have been enticed to consider allocating to illiquid asset classes in long-term, closed-ended products. Limited partnerships have been and continue to be the structure of choice for such investments, particularly for private equity (PE) and venture capital (VC).
Against this backdrop, the Irish Government has worked to modernise and enhance the existing Irish investment limited partnership (ILP) legislation with the view to making Ireland a global location for private equity funds*. As discussed by Peter Stapleton, head of the Irish Funds & Investment Management team at Maples and Calder, the Maples Group’s law firm
Various market forces are driving prospects for alternative managers globally, with Ireland being a key destination. Persistent low interest rates are pushing institutional investors towards alternative assets. This, coupled with the Covid pandemic further curtailing appetite for bank lending, has created opportunities for managers, particularly in the debt/credit spheres.
In Ireland, accelerated growth is expected to come from the private funds sector, following the launch of the enhanced Investment Limited Partnership (ILP) in December 2020.
From its perspective, Alter Domus is poised to make the most of this new development and support its existing and prospective clients with “full-suite” offerings
By A Paris – When the Alternative Investment Fund Managers Directive was enacted, there was talk of AIFMD becoming a brand to rival UCITS. The latest enhancements to the Investment Limited Partnership (ILP) structure in Ireland may well oil the wheels in the journey to making this a reality.
Following the initial frosty reception of the AIFMD, the fund industry has grown increasingly comfortable with the regulation. This happened concurrently with the dramatic rise in institutional investors’ needs around transparency and disclosure.
Paul Whelan, CSC Global managing director, head of depositary services, comments: “AIFMD is becoming a more recognised brand. UCITS
Aurelius has acquired all shares of Panasonic’s European Consumer Battery Business Units (Panasonic Consumer Energy) from Panasonic Europe.
From its European sales headquarters in Zellik Belgium, Panasonic Consumer Energy operates two manufacturing facilities, one located in Belgium and one in Poland. Across its locations Panasonic Consumer Energy today employs around 900 people and generated revenue of approximately EUR230 million in 2019.
Panasonic Consumer Energy is one of the leading producers in the European consumer batteries market and has a long-standing history of high-quality manufacturing and distribution in the European market dating back to 1970. Its key products include alkaline
Accelmed Partners (Accelmed), a private equity firm focused on acquiring and investing in US commercial stage, lower middle market HealthTech companies, has closed its oversubscribed second fund, Accelmed Fund II (Fund II) at the fund’s hard cap of USD400 million, exceeding its original USD300 million target.
Fund II received significant backing from new investors globally, including pension funds, insurers, family offices, and high net worth individuals, as well as from existing Accelmed limited partners.
For more than a decade, Accelmed has leveraged its deep HealthTech industry experience, operational and financial expertise, and strong relationships across the field to help
Mainspring Fund Services and Aspida Group have partnered to provide Guernsey-domiciled private equity and venture capital funds with a comprehensive solution for fund administration, compliance, governance and reporting.
At the same time, the partner firms confirmed their very first launch – a USD550m Private Investor Fund. The Guernsey-domiciled Fund, which has completed its first close, is run with a global mindset, investing in growth-stage technology companies across Europe, Asia and North America. The Fund is structured with a dedicated feeder for employees, advisers and affiliates.
Through the partnership, fund managers will benefit from the focused, specialist services of Aspida for
IronNet Cybersecurity (IronNet), a cybersecurity specialist backed by private equity investor C5 Capital, is to merge with LGL Systems Acquisition Corp, a special purpose acquisition company (SPAC).
The transaction will see IronNet list on the New York Stock Exchange and trade under the ticker symbol IRNT.
IronNet merges industry-leading cybersecurity products with expert service to create a platform designed to deliver the most advanced, real-time cyber defense globally, protecting both private and public sectors. Bringing together some of the best minds in cybersecurity from industry, government and academia, IronNet was created to more effectively defend enterprises, sectors and nations
The New, one of Latin America’s fastest-growing plant-based meat brands, has secured funding from Lever VC, a global investor in the alternative protein space, and Paulo Veras, Founder and CEO of 99, Brazil’s first tech unicorn. Funding will be used to complete expansion of a 1,000 sq m production facility amid heavy demand for the company’s products at national and regional retailers.
Launched in September 2019 by Bruno Fonseca, The New produces plant-based salmon, cod, chicken, and beef products. All products are non-GMO and free of all common allergens including soy and gluten, positioning The New alongside Beyond Meat as
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
